Elevated total cholesterol in severely depressed patients: Role in cardiovascular risk?

References

• Adlersberg D, Schaefer LE, Steinberg AG, Wang CI. Age, sex, serum lipids, and coronary atherosclerosis. J Am Med Assoc 1956; 162: 618–622
   Google Scholar
• , American Psychiatric AssociationRush, JA. 2000. Handbook of psychiatric measures. Washington, DC, American Psychiatric Association
   Google Scholar
• American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders4th ed. Washington, DC, American Psychiatric Association
   Google Scholar
• Bajwa WK, Asnig GM, Sanderson WC, Irfan A, Praag HM. High cholesterol levels in patients with panic disorder. Am J Psychiatry 1992; 149: 376–378
   PubMed Web of Science ®Google Scholar
• Blazer DG, Burchett BB, Fillenbaum GG. APOE 4 and low cholesterol as risks for depression in a biracial elderly community sample. Am J Geriatr Psychiatry 2002; 10: 515–520
   PubMedGoogle Scholar
• Brendt MC. Induction of platelet-Endothelial interactions in post-capillary venules in hypercholesterolemia: critical role of P-selectin. Arterioscler Thromb Vasc Biol 2003; 23: 525–527
   PubMedGoogle Scholar
• Brown SL, Salive ME, Harris TB. Low cholesterol concentration and severe depressive symptoms in elderly people. Br Med J 1994; 308: 28–32
   Google Scholar
• Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults, The evidence report. NIH publication no. 98-4083 September. 1998, National Institutes of Health National Heart, Lung, and Blood Institute in cooperation with the National Institute of Diabetes and Digestive and Kidney Diseases
   Google Scholar
• Delva NJ, Matthews DR, Cohen PJ. Brain serotonin (5-HT) neuro-endocrine function in patients taking cholesterol-lowering drugs. Biol Psychiatry 1996; 39: 100–106
   PubMedGoogle Scholar
• Engelberg H. Low serum cholesterol and suicide. Lancet 1992; 339: 727–29
   PubMed Web of Science ®Google Scholar
• Fava M, Abraham M, Pava J, Shuster J, Rosenbaum J. Cardiovascular risk factors in depression: The role of anxiety and anger attack. Psychosomatics 1996; 37: 31–37
   PubMedGoogle Scholar
• First MB, Spitzer RL, Gibbon M, Williams JBW. The Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV). American Psychiatric Press, Washington, DC 1997
   Google Scholar
• Fraguas R, Iosifescu DV, Bankier B, Perlis R, Clementi-Craven N, Alpert J, et al. Major depressive disorder with anger attacks and cardiovascular risk factors. Int J Psychiatry Med 2007; 37(1)99–111
   PubMed Web of Science ®Google Scholar
• Freedman DS, Byers T, Barrett DH, Stroup NE, Eaker E, Monroe-Blum H. Plasma lipid levels and psychologic characteristics in men. Am J Epidemiol 1995; 141: 507–517
   PubMed Web of Science ®Google Scholar
• Gold PW, Drevets WC, Charney DS. New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biol Psychiatry 2002; 52: 381–385
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr 1960; 23: 56–62
   PubMed Web of Science ®Google Scholar
• Harding TW, Climent CE, Diop M, Giel R, Ibrahim HH, Murthy RS, et al. The WHO collaborative study of strategies for extending mental health care. II: The development of new research methods. Am J Psychiatry 1983; 140: 1474–1489
   PubMed Web of Science ®Google Scholar
• Heron DS, Shinitzky M, Hershkowitz M, Samuel D. Lipid fluidity modulates the binding of serotonin to mouse brain membrane. Proc Natl Acad Sci USA 1980; 77: 7463–7467
   PubMed Web of Science ®Google Scholar
• Hillbrand M, Spitz RT. Introduction. Lipids, health and behavior, M Hillbrand, RT Spitz. American Psychological Association, Washington, DC 1997; 1–10
   Google Scholar
• Huang TL. Serum lipid profiles in major depression with clinical subtypes, suicide attempts and episodes. J Affect Disord 2005; 86: 75–79
   PubMed Web of Science ®Google Scholar
• Huang TL, Chen JF. Lipid and lipoprotein levels in depressive disorders with melancholic feature or atypical feature and dysthymia. Psychiatr Clin Neurosci 2004; 58: 295–299
   PubMedGoogle Scholar
• Iribarren C, Reed DM, Wergowske G, Burchfiel CM, Dwyer JH. Serum cholesterol level and mortality due to suicide and trauma in the Honolulu heart program. Arch Intern Med 1995; 155: 695–700
   PubMedGoogle Scholar
• Kaplan JR, Shively CA. Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosom Med 1994; 56: 479–484
   PubMed Web of Science ®Google Scholar
• Lang S, Haits G. Blutserumcholesterinwerte bei depression. Deutsche Gesundheitswesen 1968; 23: 82–84
   PubMedGoogle Scholar
• Lara N, Baker GB, Archer SL, Le Mellédo JM. Increased cholesterol levels during paroxetine administration in healthy men. J Clin Psychiatry 2003; 64(12)1455–1459
   PubMed Web of Science ®Google Scholar
• Law M. Having too much evidence (depression, suicide, and low serum cholesterol). Br Med J 1996; 313: 651–652
   PubMedGoogle Scholar
• Lindberg G, Rastam L, Gulberg B, Ekund GA. Low serum cholesterol concentration and short-term mortality from injuries in men and women. Br Med J 1992; 305: 277–279
   PubMed Web of Science ®Google Scholar
• Maes M, Delanghe J. Lower degree of esterification of serum cholesterol in depression: relevance for depression and suicide research. Acta Psychiatr Scand 1994; 90: 252–258
   PubMed Web of Science ®Google Scholar
• Maes M, Smith R. Lower serum high-density lipoprotein cholesterol in major depression and in depressed men with serious suicidal attempts: relationship with immune inflammatory markers. Acta Psychiatr Scand 1997; 95: 212–221
   PubMed Web of Science ®Google Scholar
• Mantel-Teeuwisse AK, Kloosterman JME, Maitland-van der Zee AH, Klungel OH, Porsius AJ, de Boer A. Drug-induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Saf 2001; 24: 443–456
   PubMed Web of Science ®Google Scholar
• McCallum J, Simons L, Simons J, Friedlander Y. Low serum cholesterol is not associated with depression in the elderly: data from an Australian community study. Aust NZ J Med 1994; 24: 561–564
   PubMedGoogle Scholar
• Morgan RE, Palinkas LA. Plasma cholesterol and depressive symptoms in older men. Lancet 1993; 341: 75–78
   PubMed Web of Science ®Google Scholar
• Muldoon MF, Kaplan JR. Effects of low fat diet on brain serotonergic responsivity in cynomolgus monkeys. Biol Psychiatry 1992; 31: 739–742
   PubMed Web of Science ®Google Scholar
• Muldoon MF, Manuck SB, Mathews KM. Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials. Br Med J 1990; 301: 309–314
   PubMed Web of Science ®Google Scholar
• Möller-Leimkühler AM. Women with coronary artery disease and depression: A neglected risk group. World J Biol Psychiatry 2007; 9: 92–101
   Google Scholar
• Mössner R, Mikova O, Koutsilieri E, Saoud M, Ehlis AC, Müller N, et al. Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry 2007; 8(3)141–174
   PubMed Web of Science ®Google Scholar
• Nakao M, Yano E. Relationship between major depression and high serum cholesterol in Japanese men. Tohoku J Exp Med 2004; 204: 273–287
   PubMed Web of Science ®Google Scholar
• Narayanan S. The preanalytic phase: An important component of laboratory medicine. Am J Clin Pathol 2000; 113: 429–452
   PubMed Web of Science ®Google Scholar
• Neaton JD, Blackburn JD, Jacobs D. Serum cholesterol level and mortality findings in for men screened in multiple risk factor intervention trial. Arch Intern Med 1992; 152: 1490–1500
   PubMed Web of Science ®Google Scholar
• Nicholas LM, Ford AL, Esposito SM, Ekstrom RD, Golden RN. The effects of mirtazapine on plasma lipid profiles in healthy subjects. J Clin Psychiatry 2003; 64(8)883–889
   PubMed Web of Science ®Google Scholar
• Olusi SO, Fido AA. Serum lipid concentration in patients with major depressive disorder. Biol Psychiatry 1996; 40: 1128–1131
   PubMed Web of Science ®Google Scholar
• Ormiston T, Wolkowitz OM, Reus VI, Manfredi F. Behavioral implications of lowering cholesterol levels: a double-blind pilot study. Psychosomatics 2003; 44: 412–414
   PubMed Web of Science ®Google Scholar
• Oxenkrug GF, Branconnier RJ, Harto-Truax N, Cole JO. Is serum cholesterol a biological marker for major depressive disorder?. Am J Psychiatry 1983; 140: 7–8
   Google Scholar
• Papakostas GI, Ongur D, Iosifescu DV, Mischoulon D, Fava M. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. Eur Neuropsychopharm 2004; 14: 135–142
   PubMed Web of Science ®Google Scholar
• Patient's statistical report for the years 1987–1991. 1993. Chandigarh, Department of Psychiatry: PGIMER
   Google Scholar
• Pekkanen J, Nissinen A, Punsar S, Karvonen MJ. Serum cholesterol and risk of accidental or violent death in a 25-year follow-up: The Finnish cohorts of the seven countries study. Arch Intern Med 1989; 149: 1589–1591
   PubMed Web of Science ®Google Scholar
• Rabe-Jablonska J, Poprawska I. Levels of serum total cholesterol and LDL cholesterol in patients with major depression in acute period and remission. Med Sci Monit 2000; 6: 539–547
   PubMedGoogle Scholar
• Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–1389
   PubMed Web of Science ®Google Scholar
• Ringo DL, Lindley SE, Faull KF, Faustman WO. Cholesterol and serotonin:seeking a possible link between blood cholesterol and CSF 5-HIAA. Biol Psychiatry 1994; 35: 957–959
   PubMedGoogle Scholar
• Rush, AJ, Pincus, HA, First, MB, Blacker, E, , et al. 2000. Handbook of psychiatric measures. Washington, DC, American Psychiatric Association. 527
   Google Scholar
• Sarchiapone M, Camardese G, Roy A, Della Casa S, Satta MA, Gonzalez B, et al. Cholesterol and serotonin indices in depressed and suicidal patients. J Affect Disord 2001; 62: 217–219
   PubMed Web of Science ®Google Scholar
• Scanlon SM, Williams C, Schloss P. Membrane cholesterol modulates serotonin transporter activity. Biochemistry 2001; 40: 10507–10513
   PubMedGoogle Scholar
• Severs NJ. Low serum cholesterol and suicide. Lancet 1992; 339: 1001
   PubMed Web of Science ®Google Scholar
• Singh, K, Singh, A. 2008. Changes in plasma fibrinogen, homocysteine and lipid profile in coronary artery disease patients of north Indian (Punjab) population. Biomedical Res. 19, (2) (accessed on 24 September 2008 from http://www.indmedica.com/journals.php).
   Google Scholar
• Singh S, Venketesh S, Verma JS, Verma M, Lellamma CO, Goel RC. Paraoxonase (PON1) activity in North-West Indian Punjabis with coronary artery disease and type 2 diabetes mellitus. Indian J Med Res 2007; 125: 783–787
   PubMedGoogle Scholar
• Singhal A. Mood disorders: epidemiology. Essentials of postgraduate psychiatry1st ed, JN Vyas, SS Nathawat, M Gada, V Razdan. Paras Publishers, Hyderabad 2005; I: 503–511
   Google Scholar
• Snehalatha C, Viswanathan V, Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care 2003; 26(5)1380–1384
   PubMed Web of Science ®Google Scholar
• Sonawalla S, Papakostas GI, Petersen T, Yeung AS, Smith M, Sickinger AH, et al. Elevated cholesterol levels in major depressive disorder associated with non response to fluoxetine treatment. Psychosomatics 2002; 43: 310–316
   PubMed Web of Science ®Google Scholar
• Steinberg HO, Bayazeed B, Hook G, Johnson A, Cronin J, Baron AD. Endothelial dysfunction is associated with Cholesterol levels in the high normal range in humans. Circulation 1997; 96: 3287–3293
   PubMed Web of Science ®Google Scholar
• Strandburg TE, Valvanne J, Tilvis RS. Serum lipids and depression. Lancet 1993; 342: 433–434
   Google Scholar
• Tanskanen A, Vartiainen E, Tuomilehto J, Viinamäki H, Lehtonen J, Puska P. High serum cholesterol and risk of suicide. Am J Psychiatry 2000; 157: 648–650
   PubMed Web of Science ®Google Scholar
• Terao T, Iwata N, Kanazawa K, Takano T, Takahashi N, Hayashi T, et al. Low serum cholesterol levels and depressive state in human dock visitors. Acta Psychiatr Scand 2000; 101: 231–234
   PubMedGoogle Scholar
• Tsai SJ. Statins may enhance the proteolytic cleavage of proBDNF: Implications for the treatment of depression. Med Hypotheses 2007; 68: 1296–1299
   PubMed Web of Science ®Google Scholar
• Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, et al. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 2007; 32(2)151–159
   PubMed Web of Science ®Google Scholar
• Weidner G, Conner SL, Hollis JF, Conner WE. Improvements in hostility and depression in relation to dietary change and cholesterol lowering. Ann Intern Med 1992; 117: 820–823
   PubMed Web of Science ®Google Scholar
• WHO expert consultation. 2004. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 363: 157–163
   PubMed Web of Science ®Google Scholar
• Wulsin LR. Is depression a major risk factor for coronary disease? A systematic review of the epidemiologic evidence. Harv Rev Psychiatry 2004; 12: 79–93
   PubMed Web of Science ®Google Scholar